brl 44408 has been researched along with edetic acid in 1 studies
| Studies (brl 44408) | Trials (brl 44408) | Recent Studies (post-2010) (brl 44408) | Studies (edetic acid) | Trials (edetic acid) | Recent Studies (post-2010) (edetic acid) |
|---|---|---|---|---|---|
| 82 | 0 | 16 | 27,553 | 629 | 3,970 |
| Protein | Taxonomy | brl 44408 (IC50) | edetic acid (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 7.7 | |
| Beta-lactamase VIM-1 | Pseudomonas aeruginosa | 9.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Sevilla, JA; Sastre, M | 1 |
1 other study(ies) available for brl 44408 and edetic acid
| Article | Year |
|---|---|
Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Binding, Competitive; Brain; Dioxanes; Edetic Acid; Female; Guanabenz; Guanylyl Imidodiphosphate; Humans; Idazoxan; Imidazoles; Indoles; Isoindoles; Isoquinolines; Male; Piperazines; Receptors, Adrenergic, alpha; Sodium Chloride; Tritium | 1994 |